These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Enzymatic degradation pattern of polysorbate 20 impacts interfacial properties of monoclonal antibody formulations. Gregoritza K; Theodorou C; Heitz M; Graf T; Germershaus O; Gregoritza M Eur J Pharm Biopharm; 2024 Jan; 194():74-84. PubMed ID: 38042510 [TBL] [Abstract][Full Text] [Related]
7. Using Passive Microrheology to Measure the Evolution of the Rheological Properties of NIST mAb Formulations during Adsorption to the Air-Water Interface. Escobar ELN; Vaclaw MC; Lozenski JT; Dhar P Langmuir; 2024 Mar; 40(9):4789-4800. PubMed ID: 38379175 [TBL] [Abstract][Full Text] [Related]
8. Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability. Tomlinson A; Zarraga IE; Demeule B Mol Pharm; 2020 Jul; 17(7):2345-2353. PubMed ID: 32442382 [TBL] [Abstract][Full Text] [Related]
15. Gelation of a monoclonal antibody at the silicone oil-water interface and subsequent rupture of the interfacial gel results in aggregation and particle formation. Mehta SB; Lewus R; Bee JS; Randolph TW; Carpenter JF J Pharm Sci; 2015 Apr; 104(4):1282-90. PubMed ID: 25639229 [TBL] [Abstract][Full Text] [Related]
16. Evaluating the Combined Impact of Temperature and Application of Interfacial Dilatational Stresses on Surface-mediated Protein Particle Formation in Monoclonal Antibody Formulations. Griffin VP; Merritt K; Vaclaw C; Whitaker N; Volkin DB; Ogunyankin MO; Pace S; Dhar P J Pharm Sci; 2022 Mar; 111(3):680-689. PubMed ID: 34742729 [TBL] [Abstract][Full Text] [Related]
17. Free fatty acid particles in protein formulations, part 2: contribution of polysorbate raw material. Siska CC; Pierini CJ; Lau HR; Latypov RF; Fesinmeyer RM; Litowski JR J Pharm Sci; 2015 Feb; 104(2):447-56. PubMed ID: 25196966 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Super Refined™ Polysorbate 20 With Respect to Polysorbate Degradation, Particle Formation and Protein Stability. Doshi N; Fish R; Padilla K; Yadav S J Pharm Sci; 2020 Oct; 109(10):2986-2995. PubMed ID: 32679214 [TBL] [Abstract][Full Text] [Related]
19. Existence of a superior polysorbate fraction in respect to protein stabilization and particle formation? Diederichs T; Mittag JJ; Humphrey J; Voss S; Carle S; Buske J; Garidel P Int J Pharm; 2023 Mar; 635():122660. PubMed ID: 36740078 [TBL] [Abstract][Full Text] [Related]
20. Improving Prediction of Free Fatty Acid Particle Formation in Biopharmaceutical Drug Products: Incorporating Ester Distribution during Polysorbate 20 Degradation. Doshi N; Martin J; Tomlinson A Mol Pharm; 2020 Nov; 17(11):4354-4363. PubMed ID: 32941040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]